Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03523195 · ClinicalTrials.gov registry record · NA
Exercise Intervention After Cancer Treatment for Improving Health in Stage II-III Breast Cancer Survivors
A NA study, sponsored by Fred Hutchinson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT03523195: Completed NA study, sponsored by Fred Hutchinson Cancer Center.
NCT03523195 is a NA study that has completed, run by Fred Hutchinson Cancer Center. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03523195, a NA study, has completed, sponsored by Fred Hutchinson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This pilot trial studies how well exercise intervention after cancer treatment works in improving physical activity in stage II-III breast cancer survivors. An exercise intervention may promote regular physical activity.
Primary Outcome
Will assess the percent of expected onsite sessions attended by participants as determined by Prevention Center attendance log.
Interventions
- OTHER Laboratory Biomarker Analysis
- OTHER Questionnaire Administration
- BEHAVIORAL Exercise Intervention
- OTHER Informational Intervention
- DEVICE Monitoring Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2018-04-18 |
| Est. Completion | 2019-07-15 |
| Phase | NA |
What the finished NCT03523195 record still lists
NCT03523195 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 5 interventions - of which Laboratory Biomarker Analysis is the first listed.
NCT03523195 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03523195 about?
NCT03523195 is a clinical study titled "Exercise Intervention After Cancer Treatment for Improving Health in Stage II-III Breast Cancer Survivors". This pilot trial studies how well exercise intervention after cancer treatment works in improving physical activity in stage II-III breast cancer survivors. An exercise intervention may promote regular physical activity.
What is the current status of trial NCT03523195?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2018-04-18. Estimated completion is 2019-07-15.
What interventions are being tested in trial NCT03523195?
The interventions under investigation include: Laboratory Biomarker Analysis (OTHER), Questionnaire Administration (OTHER), Exercise Intervention (BEHAVIORAL), Informational Intervention (OTHER), Monitoring Device (DEVICE).
Who is sponsoring clinical trial NCT03523195?
This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03523195's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI